More on GANX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)
- Holders

Upcoming Events

- Earnings (5/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Gain Therapeutics (NQ:GANX)
Delayed: 3.05 +0.54 (21.51%)
Prev. Close $2.51  
Open$2.48 
52 Wk High$ 
52 Wk Low$ 
Day High$3.07 
Day Low$2.46 
P/E N/A  
EPS$ 
Volume1,530,143 


Feb 19, 2026 07:00 AM Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 3, 2026 04:25 PM Form 8-K Gain Therapeutics, Inc. For: Feb 03
Jan 7, 2026 07:00 AM Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
Jan 6, 2026 07:00 AM Gain Therapeutics reports biomarker data from Parkinson's trial
Jan 6, 2026 07:00 AM Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
Dec 22, 2025 08:52 AM Gain Therapeutics (GANX) PT Raised to $10 at Roth/MKM
Dec 18, 2025 04:05 PM Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Dec 18, 2025 09:01 AM Form 8-K Gain Therapeutics, Inc. For: Dec 18
Dec 18, 2025 07:00 AM Gain Therapeutics reports brain target engagement in Parkinson's study
Dec 18, 2025 07:00 AM Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
View All Articles

Entities mentioned with GANX

View All Entities